top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Abstract Aims The aim of this study is to investigate whether the benefit of abciximab in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) undergoing percutaneous coronary ...

European Heart Journal, Ndrepepa, Gjin, Kastrati, Adnan, Mehilli, Julinda, Neumann, Franz-Josef, ten Berg, Jurriën, Bruskina, Olga, Dotzer, Franz, Seyfarth, Melchior, Pache, Jürgen, ...

Date : 01/02/2008 Item size : 257468 bytes
Ehjournal

Introduction Drug-eluting stents (DESs) are effective in reducing restenosis and the need for re-intervention after percutaneous coronary interventions (PCIs).1,2 Although their mid-term safety has ...

European Heart Journal, Schulz, Stefanie, Schuster, Tibor, Mehilli, Julinda, Byrne, Robert A., Ellert, Julia, Massberg, Steffen, Goedel, Julia, Bruskina, Olga, Ulm, Kurt, Schömig, Albert, ...

Date : 01/11/2009
Ehjournal

Abstract Aims In ISAR-REACT 3, 30-day outcomes in 4570 biomarker negative patients undergoing percutaneous coronary intervention (PCI) 2 h after pre-treatment with 600 mg of clopidogrel revealed less ...

European Heart Journal, Schulz, Stefanie, Mehilli, Julinda, Ndrepepa, Gjin, Neumann, Franz-Josef, Birkmeier, Katrin A., Kufner, Sebastian, Richardt, Gert, Berger, Peter B., Schömig, Albert, ...

Date : 01/03/2010 Item size : 245580 bytes
Ehjournal

Abstract Aims The aim of this study is to investigate whether the benefit of abciximab in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACSs) undergoing percutaneous coronary ...

European Heart Journal, Ndrepepa, Gjin, Kastrati, Adnan, Mehilli, Julinda, Neumann, Franz-Josef, ten Berg, Jurriën, Bruskina, Olga, Dotzer, Franz, Seyfarth, Melchior, Pache, Jürgen, ...

Date : 01/02/2008 Item size : 261955 bytes